News & Views | Published:

GENOME EDITING

Nanoparticles for CRISPR–Cas9 delivery

The DNA mutation that causes Duchenne muscular dystrophy in mice can be corrected, with minimal off-target effects, by gold nanoparticles carrying the CRISPR components.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Hsu, P.  D., Lander, E.  S. & Zhang, F. Cell 157, 1262–1278 (2014).

  2. 2.

    Doudna, J.  A. & Charpentier, E. Science 346, 1258096 (2014).

  3. 3.

    Tabebordbar, M. et al. Science 351, 407–411 (2016).

  4. 4.

    Nelson, C.  E. et al. Science 351, 403–407 (2016).

  5. 5.

    Long, C. et al. Science 351, 400–403 (2016).

  6. 6.

    Lee, K. et al. Nat. Biomed. Eng. https://doi.org/10.1038/s41551-017-0137-2 (2017).

  7. 7.

    Ramadasan-Nair, R. et al. J. Biol. Chem. 289, 485–509 (2014).

  8. 8.

    Wang, M., Glass, Z.  A. & Xu, Q. Gene Ther. 24, 144–150 (2017).

  9. 9.

    Wang, H.-X. et al. Chem. Rev. 117, 9874–9906 (2017).

  10. 10.

    Yin, H., Kauffman, K.  J. & Anderson, D.  G. Nat. Rev. Drug Discov. 16, 387–399 (2017).

  11. 11.

    Staahl, B.  T. et al. Nat. Biotechnol. 35, 431–434 (2017).

  12. 12.

    Zuris, J.  A. et al. Nat. Biotechnol. 33, 73–80 (2015).

  13. 13.

    Wang, M. et al. Proc. Natl Acad. Sci. USA 113, 2868–2873 (2016).

  14. 14.

    Ran, F. A. et al. Nat. Protoc 8, 2281–2308 (2013).

Download references

Author information

Correspondence to Qiaobing Xu.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark
Fig. 1: Genome editing via nanoparticle-mediated delivery of the CRISPR–Cas9 machinery.